Skip to content
Menu

ALX Oncology Holdings Q3 Adj. EPS $(0.13) Beats $(0.14) Estimate

Benzinga Newsdesk 1 day ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 63.89 percent increase over losses of $(0.36) per share

ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 63.89 percent increase over losses of $(0.36) per share from the same period last year.

Read at benzinga.com